Sanara MedTech
(NASDAQ) SMTI
Sanara MedTech Financials at a Glance
Market Cap
$202.71M
Revenue (TTM)
$107.51M
Net Income (TTM)
-$33.58M
EPS (TTM)
-$3.89
P/E Ratio
-5.69
Dividend
$0.00
Beta (Volatility)
1.19 (Average)
Dividend
$0.00
Beta (Volatility)
1.19 (Average)
Price
$22.56
Volume
39,965
Open
$21.90
Price
$22.56
Volume
39,965
Open
$21.90
Previous Close
$22.44
Daily Range
$21.26 - $22.65
52-Week Range
$16.05 - $35.95
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
1.19 (Average)
Price
$22.56
Volume
39,965
Open
$21.90
Previous Close
$22.44
Daily Range
$21.26 - $22.65
52-Week Range
$16.05 - $35.95
Estimated Earnings Date
Aug 12, 2026
SMTI News
SMTI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sanara MedTech
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
108
CEO
Seth Yon
Website
www.sanaramedtech.comHeadquarters
Fort Worth, TX 76102, US
SMTI Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
8%
Net Income Margin
-31%
Return on Equity
-9%
Return on Capital
15%
Return on Assets
-48%
Earnings Yield
-17.57%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$202.71M
Shares Outstanding
9.16M
Volume
39.97K
Avg. Volume
56.66K
Financials (TTM)
Gross Profit
$92.94M
Operating Income
$9.15M
EBITDA
$11.81M
Operating Cash Flow
$6.79M
Capital Expenditure
-$4.63M
Free Cash Flow
$2.16M
Cash & ST Invst.
$16.58M
Total Debt
$48.19M
Sanara MedTech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$27.80M
+18.6%
Gross Profit
$25.29M
+21.0%
Gross Margin
90.97%
N/A
Market Cap
$202.71M
N/A
Market Cap/Employee
$1.44M
N/A
Employees
141
N/A
Net Income
$458.96K
+113.0%
EBITDA
$3.23M
+65.8%
Quarterly Fundamentals
Net Cash
-$34.77M
-44.7%
Accounts Receivable
$13.62M
+14.4%
Inventory
$3.12M
-1.2%
Long Term Debt
$48.00M
+7.9%
Short Term Debt
$367.95K
+60.2%
Return on Assets
-48.47%
N/A
Return on Invested Capital
15.24%
N/A
Free Cash Flow
-$2.51M
+32.6%
Operating Cash Flow
-$2.47M
-23.3%